Today in NPC This Week: Employers eye #PBM changes, U.S. drug imports from Canada face hurdles, small-molecules cheaper yet comparable to #biosimilars, and more. ????Join NPC's President and CEO John O'Brien at the The Galien Foundation Forum on November 7 for a panel discussion on “BioPharma Pressure Points: PBMs, Pricing, Access, and the Global Supply Chain.” Dr. O'Brien will speak alongside Ariel Katz of H1, Dan Mendelson of Morgan Health, Janet Woodcock formerly of the U.S. FDA, and Zeke Emanuel of the University of Pennsylvania. Learn more and register to attend the Galien Forum?here: https://lnkd.in/gp3zd2aX Want to get NPC This Week in your inbox? Subscribe here: https://lnkd.in/ekY9Dxzr
National Pharmaceutical Council的动态
更多文章
-
In this issue: Employers eye PBM changes, U.S. drug imports from Canada face hurdles, small-molecules cheaper yet comparable to biosimilars, and more.
-
In this issue: Assessing copay offset programs, the first round of MFPs, patient access, the state of 340B and charity care, and more.
-
The explosion of 340B spending, insights on PBMs, the IRA’s impact on independent pharmacies, and more.